Founding Date | Founding Date 2001 | Founding Date 2000 |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Needham, US HQ Ness Ziona, IL | Locations Morrisville, US HQ Oslo, NO Swindon, GB |
Employees | Employees 48167% increase | Employees 2048% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) $1.1m (FY, 2020) | Revenue (est.) $78.2m (FY, 2024) |
Cost of goods | Cost of goods $61k (FY, 2020) | Cost of goods $7.2m (FY, 2024) |
Gross profit | Gross profit $1m (FY, 2020) | Gross profit $71m (FY, 2024) |
Net income | Net income ($74.8m) (FY, 2020) | Net income ($21.5m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 139.8m | Total funding raised $ 120.5m |

OptiNose develops nasal drug delivery technologies and combination drug-device therapies.
View company